RYR1 Chromosome 19

Ryanodine receptor 1
1315 variants 24 Drug Response 1291 Health Risk

Upload your DNA to see your personal genotypes for variants in RYR1.

What This Gene Does
This gene encodes a ryanodine receptor found in skeletal muscle. The encoded protein functions as a calcium release channel in the sarcoplasmic reticulum but also serves to connect the sarcoplasmic reticulum and transverse tubule. Mutations in this gene are associated with malignant hyperthermia susceptibility, central core disease, and minicore myopathy with external ophthalmoplegia. Alternatively spliced transcripts encoding different isoforms have been described. [provided by RefSeq, Jul 2008]
Gene Info
Gene Group
"Ryanodine receptors|Protein phosphatase 1 regulatory subunits"
Locus Type
gene with protein product
Location
19q13.2
Ensembl
ENSG00000196218
Associated Conditions (74)
Central core myopathy
RYR1-related disorder
King Denborough syndrome
desflurane response - Toxicity
halothane response - Toxicity
enflurane response - Toxicity
isoflurane response - Toxicity
methoxyflurane response - Toxicity
sevoflurane response - Toxicity
succinylcholine response - Toxicity
RYR1-related myopathy
Malignant hyperthermia
susceptibility to
1
Congenital multicore myopathy with external ophthalmoplegia
Malignant hyperthermia of anesthesia
Congenital myopathy with fiber type disproportion
Inborn genetic diseases
Congenital myopathy
Myopathy
+54 more conditions
Key Variants
RS118192124
Likely pathogenic; drug response
Central core myopathy, RYR1-related disorder, King Denborough syndrome
Drug Response
RS121918596
Likely pathogenic; drug response
Malignant hyperthermia, susceptibility to, 1
Drug Response
RS193922748
Likely pathogenic; drug response
RYR1-related disorder, sevoflurane response - Toxicity, Malignant hyperthermia
Drug Response
RS193922762
Likely pathogenic; drug response
Malignant hyperthermia, susceptibility to, 1
Drug Response
RS193922770
Likely pathogenic; drug response
RYR1-related disorder, desflurane response - Toxicity, halothane response - Toxicity
Drug Response
RS193922818
Likely pathogenic; drug response
RYR1-related disorder, Malignant hyperthermia, susceptibility to
Drug Response
RS193922832
Likely pathogenic; drug response
RYR1-related disorder, sevoflurane response - Toxicity, desflurane response - Toxicity
Drug Response
RS193922876
Likely pathogenic; drug response
desflurane response - Toxicity, enflurane response - Toxicity, succinylcholine response - Toxicity
Drug Response
RS193922878
Likely pathogenic; drug response
desflurane response - Toxicity, halothane response - Toxicity, isoflurane response - Toxicity
Drug Response
RS28933397
Likely pathogenic; drug response
Malignant hyperthermia, susceptibility to, 1
Drug Response
RS118192122
Pathogenic; drug response
Central core myopathy, Malignant hyperthermia, susceptibility to
Drug Response
RS118192161
Pathogenic; drug response
Malignant hyperthermia, susceptibility to, 1
Drug Response
All Variants (1315)
RSID Category Clinical Significance Conditions
RS763259167 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
RS763353979 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS763413580 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia, RYR1-related disorder
RS763655831 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS763722972 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS763905757 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS763944786 Health Risk Conflicting classifications of pathogenicity Delayed gross motor development, Scoliosis, Pelvic girdle muscle weakness
RS763954439 Health Risk Conflicting classifications of pathogenicity Central core myopathy, Malignant hyperthermia, susceptibility to
RS764290955 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Central core myopathy, Malignant hyperthermia
RS764395582 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS764527957 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS764655128 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS76537615 Health Risk Conflicting classifications of pathogenicity Malignant hypothermia, RYR1-related disorder, Malignant hyperthermia
RS765570755 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS765657226 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS765921831 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS766407858 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS766518951 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS766560974 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS766633897 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS766836202 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS767024764 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS767107632 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS767343838 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
RS767400168 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS767508472 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS767667578 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS767711818 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS767777113 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
RS767805554 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Central core myopathy, Congenital multicore myopathy with external ophthalmoplegia
RS767928113 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS768008924 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS768070268 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
RS768275402 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS768611849 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia
RS768702294 Health Risk Conflicting classifications of pathogenicity Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia, susceptibility to
RS769096297 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS769196275 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS769377982 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS769744438 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS770132934 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS770698609 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Central core myopathy, Malignant hyperthermia
RS770942162 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia
RS771306571 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia, Malignant hyperthermia
RS771523641 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS771629253 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS772003357 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS772116480 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, Malignant hyperthermia, susceptibility to
RS772422894 Health Risk Conflicting classifications of pathogenicity Malignant hyperthermia, susceptibility to, 1
RS772518280 Health Risk Conflicting classifications of pathogenicity RYR1-related disorder, RYR1-related disorder
« Prev 1 ... 10 11 12 13 14 15 16 ... 27 Next »
Sign Up to Analyze Your DNA Log In